Strotay Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 16 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 M
- Revenue Growth -8.95%
- Profit Growth -50.74%
- Ebitda 76.09%
- Net Worth 14.42%
- Total Assets -6.86%
About Strotay Life Sciences
Strotay Life Sciences Private Limited (SLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 November 2008 and has a history of 16 years and three months. Its registered office is in Gorakhpur, Uttar Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.00 M.
Vibha Pandey, Mrityunjay Shukla, and Dimple Shukla serve as directors at the Company.
Company Details
-
Location
Gorakhpur, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U52310UP2008PTC036281
-
Company No.
036281
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Nov 2008
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Strotay Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vibha Pandey
|
Director | 28-Oct-2021 | Current |
| Mrityunjay Shukla | Whole-Time Director | 22-Aug-2024 | Current |
|
Dimple Shukla
|
Director | 19-Sep-2014 | Current |
Financial Performance of Strotay Life Sciences.
Strotay Life Sciences Private Limited, for the financial year ended 2019, experienced Minor drop in revenue, with a 8.95% decrease. The company also saw a substantial fall in profitability, with a 50.74% decrease in profit. The company's net worth Soared by an impressive increase of 14.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Strotay Life Sciences?
In 2019, Strotay Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹2.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Mar 2016 | Others | ₹2.00 M | Open |
How Many Employees Work at Strotay Life Sciences?
Unlock and access historical data on people associated with Strotay Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Strotay Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Strotay Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
